Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 3
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Tobacco smoking and regression of low-grade cervical abnormalities.
Matsumoto K, Oki A, Furuta R, Maeda H, Yasugi T, Takatsuka N, Hirai Y, Mitsuhashi A, Fujii T, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T, Yoshikawa H; Japan HPV And Cervical Cancer (JHACC) Study Group. Matsumoto K, et al. Cancer Sci. 2010 Sep;101(9):2065-73. doi: 10.1111/j.1349-7006.2010.01642.x. Cancer Sci. 2010. PMID: 20626752 Free PMC article.
Subsequent risks for cervical precancer and cancer in women with low-grade squamous intraepithelial lesions unconfirmed by colposcopy-directed biopsy: results from a multicenter, prospective, cohort study.
Matsumoto K, Hirai Y, Furuta R, Takatsuka N, Oki A, Yasugi T, Maeda H, Mitsuhashi A, Fujii T, Kawana K, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T, Yoshikawa H; Japan HPV and Cervical Cancer (JHACC) Study Group. Matsumoto K, et al. Int J Clin Oncol. 2012 Jun;17(3):233-9. doi: 10.1007/s10147-011-0280-9. Epub 2011 Jul 13. Int J Clin Oncol. 2012. PMID: 21748261 Clinical Trial.
Do neutralizing antibody responses generated by human papillomavirus infections favor a better outcome of low-grade cervical lesions?
Ochi H, Matsumoto K, Kondo K, Oki A, Furuta R, Hirai Y, Yasugi T, Takatsuka N, Maeda H, Mitsuhashi A, Fujii T, Kawana K, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T, Kanda T, Yoshikawa H; Japan HPV And Cervical Cancer (JHACC) Study Group. Ochi H, et al. J Med Virol. 2012 Jul;84(7):1128-34. doi: 10.1002/jmv.23258. J Med Virol. 2012. PMID: 22585732
Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?
Matsumoto K, Maeda H, Oki A, Takatsuka N, Yasugi T, Furuta R, Hirata R, Mitsuhashi A, Kawana K, Fujii T, Iwata T, Hirai Y, Yokoyama M, Yaegashi N, Watanabe Y, Nagai Y, Yoshikawa H; Japan HPV and Cervical Cancer (JHACC) Study Group. Matsumoto K, et al. Cancer Sci. 2015 Oct;106(10):1448-54. doi: 10.1111/cas.12760. Epub 2015 Sep 25. Cancer Sci. 2015. PMID: 26235935 Free PMC article.
HLA class II DRB1*1302 allele protects against progression to cervical intraepithelial neoplasia grade 3: a multicenter prospective cohort study.
Matsumoto K, Maeda H, Oki A, Takatsuka N, Yasugi T, Furuta R, Hirata R, Mitsuhashi A, Fujii T, Hirai Y, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T, Yoshikawa H; for Japan HPV And Cervical Cancer (JHACC) Study Group. Matsumoto K, et al. Int J Gynecol Cancer. 2012 Mar;22(3):471-8. doi: 10.1097/IGC.0b013e3182439500. Int J Gynecol Cancer. 2012. PMID: 22391763